EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Subclinical inflammation in children with Down syndrome: implications for preventive care

Charu Sharma, Muhammad Jawad Hashim, Tarek El Azzabi, Sania Al Hamad, Ekhlass Mohammed, Javed Yasin, Yousef M Abdulrazzaq, Elhadi Husein Aburawi

Annals of Pediatric Endocrinology & Metabolism · 30.04.2026 · 31 (2) · 119-128

DOI: 10.6065/apem.2550148.074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pediatric Endocrinology & Metabolism, erschienen am 30.04.2026. Verfasst von Charu Sharma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: United Arab Emirates University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Down syndrome (DS) is associated with metabolic dysregulation, obesity, and increased risk of chronic inflammation. This study aimed to assess subclinical inflammation in children with DS by evaluating inflammatory biomarkers, such as high-sensitivity C-reactive protein (hs-CRP), and their association with metabolic parameters including ghrelin, lipid profiles, and vitamin D levels.

Methods

A total of 49 children with DS (aged 1–18 years) and 22 age-matched healthy controls were enrolled. Anthropometric data, body fat percentage, and metabolic parameters were assessed. Inflammatory markers (hs-CRP, apolipoprotein-B [Apo B], adiponectin), metabolic hormones (ghrelin, insulin), and lipid profiles were determined from venous blood samples. Statistical analyses included bivariate correlation, analysis of variance, and multiple linear regression to identify predictors of inflammation.

Results

Children with DS exhibited significantly higher hs-CRP levels than controls (p=0.03), indicative of increased systemic inflammation. Higher hs-CRP levels were associated with older age (r=0.33, p=0.006), greater obesity (body mass index: r=0.32, p=0.011), and elevated serum insulin and low-density lipoprotein levels. Ghrelin levels correlated negatively with Apo B (r=-0.41, p

Schlagwörter

Stichwörter der Autor:innen

ChildDown syndromeGhrelinHigh-sensitivity C-reactive proteinInflammationMetabolic DysfunctionUnited Arab Emirates

Autor:innen und Institutionen

  • Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
  • Department of Family Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
  • Department of Pediatrics, Al Ain Hospital, Al Ain, UAE.
  • Department of Pediatrics, Sheikh Khalifa Medical City Hospital, Al Ain, UAE.
  • Department of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
  • Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.

Förderung

  • United Arab Emirates University

Zitieren

APA

Sharma, C., Hashim, M. J., Azzabi, T. E., Hamad, S. A., Mohammed, E., Yasin, J., Abdulrazzaq, Y. M., & Aburawi, E. H. (2026). Subclinical inflammation in children with Down syndrome: implications for preventive care. Annals of Pediatric Endocrinology & Metabolism, 31(2), 119-128. https://doi.org/10.6065/apem.2550148.074

Vancouver

Sharma C, Hashim MJ, Azzabi TE, Hamad SA, Mohammed E, Yasin J, et al. Subclinical inflammation in children with Down syndrome: implications for preventive care. Annals of Pediatric Endocrinology & Metabolism. 2026;31(2):119-128. doi:10.6065/apem.2550148.074

BibTeX
@article{Sharma2026,
  author = {Sharma, Charu and Hashim, Muhammad Jawad and Azzabi, Tarek El and Hamad, Sania Al and Mohammed, Ekhlass and Yasin, Javed and Abdulrazzaq, Yousef M and Aburawi, Elhadi Husein},
  title = {Subclinical inflammation in children with Down syndrome: implications for preventive care},
  journal = {Annals of Pediatric Endocrinology & Metabolism},
  year = {2026},
  volume = {31},
  number = {2},
  pages = {119--128},
  doi = {10.6065/apem.2550148.074}
}
Kostenlos starten →